FIELD: bioengineering.
SUBSTANCE: claimed invention discloses the production of the cells being the derivatives of human cardiac tissue, that do not express telomerase and Isl-l and express CD117. Besides, it discloses the compositions including the cleaned population of the cells thus produced to be used for the recovery of the damaged myocardium with the help of the human cells of a cardiac origin.
EFFECT: perfected properties.
19 cl, 39 dwg, 30 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELLS DERIVED FROM CARDIAC TISSUE | 2010 |
|
RU2662675C1 |
| CELLS DERIVED FROM CARDIAL TISSUE | 2010 |
|
RU2642282C1 |
| PHARMACEUTICAL PREPARATION | 2009 |
|
RU2542512C2 |
| METHOD FOR PREPARATION AND INDUCTION OF DIRECTIONAL DIFFERENTIATION OF MULTIPOTENT CARDIAC CELL CULTURE FOR CELL-BASED THERAPY AND/OR TISSUE ENGINEERING WITHIN MYOCARDIAL ISCHEMIA | 2008 |
|
RU2366706C1 |
| METHOD OF PRODUCING FIBROBLASTS AND G-CSF-POSITIVE FIBROBLAST MASS | 2019 |
|
RU2800644C2 |
| METHOD FOR OBTAINING AND APPLICATION OF TISSUE ENGINEERING STRUCTURES BASED ON PROGENITAL CELLS FOR HEART DISEASES TREATMENT | 2015 |
|
RU2636464C2 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
| APPLICATION OF COMPOSITION CONSISTING OF CONCENTRATED CELL POPULATION REPRESENTING STEM CELLS AND UNDIFFERENTIATED PRECURSORS | 2004 |
|
RU2372924C2 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
| COMPOSITIONS IMPROVING MYOCARDIAL INFARCTION PERFUSION AND METHODS FOR REGENERATION AFTER VASCULAR INJURY | 2013 |
|
RU2550959C2 |
